Genky DrugStores Co., Ltd.

9267.T
Pharmaceutical Retailers
2026/07/28 Updated
Market Cap: $735.6M (¥120.4B)
Stock Price: $24.13 (¥3,950)
Exchange Rate: 1 USD = ¥163.67

Genky FY2026 June Financial Summary|Sales ¥220.6 billion (YoY +9.9%)

Genky announced its financial results for the fiscal year ending June 2026, with sales of ¥220.6 billion (YoY +9.9%), operating income of ¥109.5 billion (YoY +8.4%), and net income of ¥70.8 billion (YoY +11.4%), achieving increases in both revenue and profit.

Importance:
Page Updated: July 28, 2026
IR Disclosure Date: July 28, 2026

Key Figures

  • Sales: ¥220.6 billion (YoY +9.9%)
  • Operating income: ¥109.5 billion (YoY +8.4%)
  • Net income: ¥70.8 billion (YoY +11.4%)

AI要約

Performance Overview

Genky announced its financial results for the fiscal year ending June 2026, with sales of ¥220.6 billion (YoY +9.9%), operating income of ¥109.5 billion (YoY +8.4%), and net income of ¥70.8 billion (YoY +11.4%), achieving growth in both revenue and profit. The company's stable growth is supported by new store openings and sales expansion at existing stores.

Future Outlook

The company will continue aggressive store openings and sales expansion at existing stores, aiming for increased revenue and profit in the fiscal year ending June 2027. Its low-price strategy and locally-focused store development will help maintain competitiveness and expand market share.

Sales Trend

Operating Income Trend

Net Income Trend

Segment Revenue Breakdown

Profit Margin Analysis

This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.

Genky Co., Ltd.

Company overview · Stock price · Financial data · All IR

View company page →